Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
27.35
+0.02 (0.07%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Arcutis Biotherapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $35 | Buy | Reiterates | $35 | +27.97% | Jul 17, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $35 | Buy | Reiterates | $35 | +27.97% | Jul 15, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $35 | Buy | Maintains | $35 | +27.97% | Jul 9, 2026 |
| Needham | Needham | Buy Maintains $36 | Buy | Maintains | $36 | +31.63% | Jun 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $34 | Buy | Reiterates | $34 | +24.31% | May 11, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $35 → $34 | Buy | Maintains | $35 → $34 | +24.31% | May 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $35 | Buy | Maintains | $35 | +27.97% | May 7, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $29 → $33 | Hold | Maintains | $29 → $33 | +20.66% | Feb 27, 2026 |